Further details on identity and specification of active substance are provided in the review report.    ,

‘334,  Oryzalin    CAS No: 19044-88-3     CIPAC No: 537  , 3,5-dinitro-N4,N4-dipropylsulfanilamide ,  ≥ 960 g/kg    N-nitrosodipropylamine:    ≤ 0,1 mg/kg    Toluene: ≤ 4 g/kg  ,1 June 2011,31 May 2021,  PART A   Only uses as herbicide may be authorised.     PART B   For the implementation of the uniform principles of Annex VI the conclusions of the review report on oryzalin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 January 2011, shall be taken into account.    In this overall assessment Member States shall pay particular attention to:       the operator safety and ensure that conditions of use include the application of adequate personal protective equipment;      the protection of aquatic organisms and non-target plants;      the protection of groundwater, where the active substance is applied in regions with vulnerable soil and/or climatic conditions;      the risk to herbivorous birds and mammals;      the risk to bees, in the flowering season.       Conditions of authorisation shall include risk mitigation measures, where appropriate.    The Member States concerned shall carry out monitoring programmes to verify potential groundwater contamination from the metabolites OR13 (2-ethyl-7-nitro-1-propyl-1H-benzimidazole-5-sulfonamide) and OR15 (2-ethyl-7-nitro-1H-benzimidazole-5-sulfonamide) in vulnerable zones, where appropriate. The Member States concerned shall request the submission of confirmatory information as regards:       the specification of the technical material, as commercially manufactured, by appropriate analytical data, including information on the relevance of the impurities which for confidentiality reasons are referred to as impurities 2, 6, 7, 9, 10, 11, 12;      the relevance of the test material used in the toxicity dossiers in view of the specification of the technical material;      the risk assessment for aquatic organisms;      the relevance of the metabolites OR13 and OR15, and the corresponding groundwater risk assessment, provided that oryzalin becomes classified under Regulation (EC) No 1272/2008 of the European Parliament and of the Council ( OJ L 353, 31.12.2008, p. 1 ) as “suspected of causing cancer”.       The Member States concerned shall ensure that the applicant submits to the Commission the information set out in points 1 and 2 by 1 December 2011, and the information set out in point 3 by 31 May 2013. The information set out in point 4 shall be submitted within 6 months of notification of a decision classifying oryzalin.’   ,